Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Arthritis Ireland
Talk to us: 01 661 8188 / 0818 252 846
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Linkedin
Helpline Donate
  • Twitter
Menu
  • About us
    • Why we exist
    • News
    • Who we are
      • Our team
      • Our board
    • Finances
    • Strategic plan
    • Job opportunities
  • About arthritis
    • Conditions
    • Booklets
    • Medications
      • Biosimilars
    • Physical activity
    • Pregnancy and arthritis
    • Work and Arthritis
  • Get help
    • Covid-19 (coronavirus)
    • Newly diagnosed
    • Coping with Emotions
    • Get Support
      • Call our helpline
      • Peer-to-peer network
    • Volunteer
    • Complementary therapies
    • Healthcare team
    • Take Control with Exercise
    • Healthy eating
  • In your area
    • Our branches
    • Activites in your area
      • Clare
      • Cork
      • Donegal
      • Dublin
      • Galway
      • Kerry
      • Kildare
      • Kilkenny
      • Limerick
      • Longford
      • Louth
      • Mayo
      • Sligo
      • Waterford
      • Westmeath
      • Wexford
  • Support us
    • Donate
    • Fundraise
      • Get involved
      • Fundraising ideas and materials
      • Virtual fundraisers
      • Stories
      • Fundraisers
        • Create a fundraiser
    • Leave a legacy
    • Corporate partnerships
    • Become a Friend
  • Courses
    • Living Well with Arthritis Online
    • Living Well with Arthritis
    • Breaking the Pain Cycle
    • Be Active with Arthritis online
    • Be Active with Arthritis
    • Take Control with Exercise
  • Research
    • Covid-19 impact survey
    • Research we are funding
    • Arthritis Research Coalition Biobank
    • Research prioritisation exercise
    • Working on a cure
  • Shop
  • Admin
    • Log in
  • Basket: (0 items)
  • Covid-19 (coronavirus)
  1. Get help
  2. Covid-19 (coronavirus)

Covid-19 (coronavirus)

Information on Covid-19 - Vaccination, Priority Lists, and Timing of Vaccination

Vaccine Allocation Strategy - Update from Minister Stephen Donnelly

Information on vaccines for patients on immunosuppressives

Guidance for vaccination in rheumatology patients

Which groups of rheumatology patients should be prioritised for Covid-19 vaccination?

Recommendations on selection of Covid-19 vaccine by patient sub-group

Recommendations for the optimal timing of Covid-19 vaccination

National framework for living with Covid-19 

Symptoms of Covid-19 and how to protect yourself

Update on the Vaccine Allocation Strategy - 23 February 2021

The Government announced some changes to the vaccine allocation priority lists on 23 February. 

The changes are based on the latest clinical and medical advice that those being moved up the list would suffer the worst outcomes if they were to get the disease.

Cohort 4, who will be vaccinated immediately after the over 70s living in the community, will now be those aged 16-69 with a medical condition that puts them at very high risk of severe disease and death.

Severe immunocompromise due to disease or treatment, under the following conditions, would lead to vaccination in Cohort 4.

Transplantation: - Listed for solid organ or haematopoietic stem cell transplant (HSCT) - Post solid organ transplant at any time - Post HSCT within 12 months Genetic diseases: - APECED** - Inborn errors in the interferon pathway

Treatment: - included but not limited to Cyclophosphamide, Rituximab, Alemtuzumab, Cladribine or Ocrelizumab in the last 6 months. 

Medical conditions and the magnitude of the risk they pose will continue to be monitored and periodically reviewed.

For more information click here.

Back to top

Information from the HSE for patients on immunosuppressives re the Covid vaccines:

The Oxford-AstraZeneca non-replicating vector vaccine is deemed safe for patients on immunosuppressives. The Pfizer-BioNTech and Moderna mRNA vaccines are not live vaccines and are recommended for patients on immunosuppressives.

Back to top

Specific Guidance for Covid-19 vaccination in rheumatology patients (VCD19-001-001/12.02.2021) 

  • Published 12 February 2021, HSE National Health Library & Knowledge Service
  • Prof David Kane, National Clinical Programme for Rheumatology (1/1/21)
  • Influenza and Pneumococcal vaccination are recommended for all rheumatology patients receiving immunotherapy and ALL patients being considered for SARS-CoV-2 vaccination should be strongly advised to have Influenza and Pneumococcal vaccinations. There is very good quality evidence of mortality reduction for patients who have influenza and pneumococcal vaccination.

Back to top

Which (if any) groups of Rheumatology patients should be prioritized for Covid-19 vaccination?

  • In addition to existing known high risk groups, rheumatology patients on the following immunosuppressives should be prioritized for Covid-19 vaccination as they have a higher risk of hospitalization / death from COVID-19 while all other rheumatology patients on immunosuppressives will be offered the vaccine in due course.
  • High Risk*
    People taking Prednisolone at low to moderate doses (5mg/ day1 or greater but less than 10mg day) for 2 weeks or longer (or equivalent doses, see section 3).
  • Very High risk
    Prednisolone 40 mg/day3 or greater for more than 1 week, or 10mg/day or greater for 2 weeks or longer
    Or
    Cyclophosphamide, Rituximab, Alemtuzumab, Cladribine or Ocrelizumab in the last 6 months.
    Or
    People with autoimmune disease and with clinical immunosuppression manifest by recurrent infections and/or significant laboratory evidence of immunosuppression (severe neutropenia (ANC less than 0.5 x 109/L), lymphopenia & hypogammaglobulinaemia).”

* From HSE COVID-19: Interim Clinical Guidance: Immunosuppressant Therapy v5 updated 29th October 2020)

Back to top

Recommendations for selection of Covid-19 vaccine by patients sub-group

  • There will be a number of Covid-19 vaccines with different mechanisms. The HSE has concluded agreements with 5 suppliers for the main vaccine designs (mRNA (Moderna, Pfizer), non-replicating vector vaccines (University of Oxford) and inactivated virus vaccines).

  • The Pfizer-BioNTech mRNA and Moderna mRNA vaccines which are currently licensed are not live vaccines and are recommended for patients on immunosuppressives.

  • The Oxford-AstraZeneca non-replicating vector vaccine is also deemed safe for patients on immunosuppressives.

Back to top

Recommendations for optimal timing of administration of Covid-19 vaccine

(a) Patients on Methotrexate

  • Several studies have addressed the optimal timing of Influenza vaccination in rheumatology patients on low dose methotrexate and of Influenza and pneumococcal vaccination in rheumatology and oncology patients on Rituximab.
  • Patients on methotrexate who held their medication for 2 weeks after administration of influenza vaccination had a 4 fold increase in neutralizing antibody titres without a significant increased risk of disease flare compared to those who did not interrupt their MTX dosing. Longer periods of treatment interruption up to 4 weeks showed no increased benefit. It is not known if this translates into reduced influenza infection rates though the supposition that it does is logical based on what we know about vaccines and how they work.
  • For surgery it is already established practice to time surgery at the end of a biologic treatment cycle and restart at 10-14 days after to reduce peri-operative infection and minimize flare.
  • Therefore depending on your patient’s circumstances you may recommend that where possible patients on methotrexate should ideally schedule Covid-19 vaccination at the end of a treatment cycle and hold treatment for a maximum of 2 weeks if the treating clinician and patient agree on this strategy.
    There is no evidence that this strategy is of benefit with other DMARDs.

(b) Patients on Corticosteroids

  • It is not possible for patients on steroids to discontinue treatment for the purposes of Covid-19 vaccination - minimization of steroid dose under supervision of their doctor where possible may be of benefit to patients receiving the vaccine

(c) Patients on Rituximab

  • Patients on rituximab have reduced numbers of B cells and a poorer antibody generation response to vaccines. It is recommended that patients should have Covid-19 vaccination ideally 4 weeks before they receive rituximab treatment and if on treatment that it be scheduled for the end of a treatment cycle (e.g. 6 months after last dose for optimal effect).
  • In patients approaching a new treatment cycle in Q1 2021, clinicians should now consider identifying and pausing therapy if they can predict availability of vaccination for that patient. Clearly the main difficulty is predicting timing of vaccination for these patients.

Back to top

National Framework for living with Covid-19

Ireland is currently placed on Level 5 restrictions: for full details of the measures that are now in place please follow this link.
Covid-19 and arthritis
  • Do not alter your medications without specific instructions to do so by your rheumatology team, who have your medical records. If you develop symptoms of any infection, including Covid-19, in consultation with your rheumatology team, immunosuppressive therapy should be paused for the duration of the infection until you feel well.
  • Being on immunosuppressive treatments does not increase your risk of getting a Covid-19 (Coronavirus) infection 
  • There is no evidence to date that being on an immunosuppressive treatment puts you at higher risk of severe disease with Covid-19.
  • However, as other infections can cause severe illness in people who are on immunosuppressive treatment, you should take extra care. 
  • Keep taking steroids if you are usually on them unless your doctor tells you otherwise. Stopping steroids suddenly can make you very unwell. If you become unwell due to Covid-19 or another infection, continue to take your steroids.
  • Further information about immunosuppressive medications, steroids and risk is available here.

If you have any questions about Covid-19, please contact our helpline by phone: 0818252846 or by email to [email protected]. You can also connect with our private Facebook support group.

Back to top

Symptoms of COVID-19 and how to protect yourself

Physical distancing should continue to be maintained at all times.

You are still advised to:

  • wash your hands well and often
  • cover your mouth and nose with a tissue or bent elbow when coughing or sneezing, and discard used tissue safely
  • distance yourself at least 2 metres away from other people, especially those who might be unwell
  • limit your contact with others when out and about
  • keep your close contacts to a small number of people
  • limit the amount of time you spend in direct contact with other people
  • avoid crowded areas. If an area looks busy, go somewhere else or return at a quieter time
  • wear a face covering in situations where physical distancing is not possible, for example shops and busy public transport, or if you are meeting someone who is vulnerable to the virus, for example people who are extremely medically vulnerable and people over 70 years. Wearing cloth face coverings may help prevent people who do not know they have the virus from spreading it to others. Guidance on safe use of face coverings is available here.
  • keep a log of all of your contacts throughout the day

Know the symptoms of Covid-19.

They are:

  • a fever (high temperature - 38 degrees Celsius or above)
  • a cough - this can be any kind of cough, not just dry
  • shortness of breath or breathing difficulties
  • loss or change to your sense of smell or taste
  • flu like symptoms

If you have symptoms, self-isolate and contact your GP immediately.

Further information about Covid-19 is available on the Department of Health website

Back to top

Updated 25 February 2021

Published: 7th January, 2021

Updated: 25th February, 2021

Author: Brian Lynch

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Virtual Coffee Morning with Occupational Therapist Brid McOsker

    Virtual Coffee Morning with Occupational Therapist Brid McOsker

    Join us for a virtual coffee morning with guest speaker Brid McOsker, Occupational Therapist at Merlin Park Hospital in Galway. Brid has extensive experience in supporting people living with arthritis overcome daily challenges both large and small.

  • Support Not Giving Up

    Support Not Giving Up

  • Walk Where You Are - Virtual Walking Group

    Walk Where You Are - Virtual Walking Group

    Walk apart but in this together. Join our WhatsApp group for walkers to share progress and photos.

  • The management of arthritis symptoms with Ellen Forkan

    The management of arthritis symptoms with Ellen Forkan

    Our Galway Branch invite you to our virtual coffee morning to meet Ellen Forkan, a GMIT Sports & Exercise 4th year student doing her placement with our branch in Galway

Related

  • Research prioritisation

    Research prioritisation

    Tell us what research questions are important to you

  • My RA Story

    My RA Story

    My RA Story is a powerful collection of personal stories of what it's like living with rheumatoid arthritis. The book has been nominated in the Irish Healthcare Awards 2020.

  • Survey highlights impact of Covid-19 on people with arthritis

    Survey highlights impact of Covid-19 on people with arthritis

    Research published by Arthritis Ireland to mark World Arthritis Day looks at the impact of Covid-19 on people living with arthritis.

  • Living Well with Arthritis online

    Living Well with Arthritis online

    Reduce your pain and reclaim your life from arthritis by signing up for our online self-management course. 32 online courses will be delivered in 2021 with 10 starting soon.

  • Psoriatic arthritis

    Psoriatic arthritis

    Learn more about living with psoriatic arthritis, with expert advice from Dr Laura Durcan and personal accounts from people living with the condition

  • Virtual fundraisers

    Virtual fundraisers

    Staying at home doesn’t mean you can’t still support people living with arthritis. There are plenty of great virtual fundraising ideas to alleviate that lockdown boredom and stay connected. Help raise vital funds for supports and services for the one million adults and 1200 children living with arthritis in Ireland.

  • MACIR (MACrophage Immunometabolism Regulator)

    MACIR (MACrophage Immunometabolism Regulator)

    Research on the gene MACIR is shown to be linked with tissue damage in rheumatoid arthritis

  • Our branches

    Our branches

    Details of what's happening around the country in the Arthritis Ireland branches

  • My backseat driver

    My backseat driver

    Replace this with your content

Most read

  • Covid-19 (coronavirus)

    Covid-19 (coronavirus)

    Important information about Covid-19 (coronavirus) for people living with arthritis

  • Benefits of physical activity highlighted for people with arthritis – National Arthritis Week launched

    Benefits of physical activity highlighted for people with arthritis – National Arthritis Week launched

    National Arthritis Week launched today (20 April) with the theme "Every Movement Matters".

  • Awareness campaign about psoriatic arthritis launched

    Awareness campaign about psoriatic arthritis launched

    Sausage-like fingers or toes; a red scaly skin rash; pitted nails; and stiff, painful, swollen joints – these are some of the symptoms of psoriatic arthritis, which Arthritis Ireland is highlighting in a new health awareness campaign.

  • Survey highlights impact of Covid-19 on people with arthritis

    Survey highlights impact of Covid-19 on people with arthritis

    Research published by Arthritis Ireland to mark World Arthritis Day looks at the impact of Covid-19 on people living with arthritis.

  • Arthritis Ireland appoints new chairman

    Arthritis Ireland appoints new chairman

    Arthritis Ireland has announced the appointment of Tim O’Sullivan as its new chairman. He replaces Seoirse Smith who leaves the board after 10 years, including three as chair.

  • UCD arthritis research conference highlights importance of self-management

    UCD arthritis research conference highlights importance of self-management

    The third annual UCD arthritis research conference will take place online on 18 November

  • Awareness campaign launched to educate patients about new treatment options

    Awareness campaign launched to educate patients about new treatment options

    An information campaign to educate and inform patients about biosimilar medicines is launched today (3 March) by Arthritis Ireland.

  • Coping with emotions

    Coping with emotions

    When you have arthritis, you will also experience a range of different emotions. Here's some information about the types of emotions you might experience living with arthritis, how to deal with difficult emotions while living with arthritis, and the supports that are available for those experiencing difficult emotions.

  • Statement re cancellation of Arthritis Ireland events due to Covid-19

    Statement re cancellation of Arthritis Ireland events due to Covid-19

    Arthritis Ireland has cancelled all events for the foreseeable future, which is based on expert advice from the HSE.

  • Communications and digital marketing executive

    Communications and digital marketing executive

Tag cloud

#powerof10 appeal arthritis Arthritis Ireland christmas Corporate power of 10 Vhi Women's mini marathon virtual challenge

Latest tweet

Arthritis Ireland
1 Clanwilliam Square
Grand Canal Quay
Dublin 2
D02 DH77

Talk to us:
01 661 8188 / 0818 252 846

Helpline

  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Linkedin

RCN: 20011123; CHY: 6297; CRO: 78931

  • Contact us
  • Jobs
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

The development of this website was supported by the following companies, however, it was created without any input from them. The content and views expressed on the website are those of Arthritis Ireland, not of the sponsors.